⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for belinostat

Every month we try and update this database with for belinostat cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Talazoparib in Combination With Belinostat for Metastatic Breast Cancer, Metastatic Castration Resistant Prostate Cancer, and Metastatic Ovarian CancerNCT04703920
Metastatic Brea...
Metastatic Cast...
Metastatic Ovar...
Talazoparib
Belinostat
18 Years - University of Michigan Rogel Cancer Center
Safety and Efficacy of Belinostat When Used With Standard of Care Chemotherapy for Untreated Non-small Cell Lung CancerNCT01090830
Non-Small-Cell ...
Belinostat, car...
18 Years - Holy Cross Hospital, Florida
Study of Oral PXD101 in Patients With Advanced Solid Tumors or LymphomaNCT00413075
Solid Tumor
Lymphoma
oral belinostat
18 Years - Valerio Therapeutics
Safety and Efficacy of Belinostat When Used With Standard of Care Chemotherapy for Untreated Non-small Cell Lung CancerNCT01090830
Non-Small-Cell ...
Belinostat, car...
18 Years - Holy Cross Hospital, Florida
A Phase Ib Study of Belinostat With RDHAP Chemotherapy (Dexamethasone, Cytarabine, Cisplatinum) in Adults With Relapsed or Refractory Diffuse Large B-cell LymphomaNCT02532192
Lymphoma
Belinostat
Rituximab
Cisplatin
Cytarabine
Dexamethasone
Ciprofloxacin
Fluconazole
18 Years - 80 YearsM.D. Anderson Cancer Center
Belinostat Therapy With Zidovudine for Adult T-Cell Leukemia-LymphomaNCT02737046
Adult T-cell Le...
ATLL
Belinostat
Zidovudine
Interferon-Alfa...
Pegylated Inter...
18 Years - University of Miami
Phase I Trial of AZD1775 and Belinostat in Treating Patients With Relapsed or Refractory Myeloid Malignancies or Untreated Acute Myeloid LeukemiaNCT02381548
Acute Myeloid L...
Blast Phase Chr...
Myelodysplastic...
Previously Trea...
Recurrent Adult...
Recurrent Chron...
Refractory Acut...
Refractory Chro...
Secondary Acute...
Therapy-Related...
Untreated Adult...
Adavosertib
Belinostat
Laboratory Biom...
Pharmacological...
18 Years - National Cancer Institute (NCI)
Belinostat, Carboplatin and Paclitaxel (BelCaP) Compared to Carboplatin and Paclitaxel in Patients With Cancer of Unknown PrimaryNCT00873119
Carcinoma of Un...
belinostat, car...
carboplatin, pa...
18 Years - Valerio Therapeutics
Phase 1 Dose Finding Study of Belinostat for Treatment of Patients With Peripheral T-cell Lymphoma (PTCL)NCT01839097
Peripheral T-ce...
Belinostat
CHOP
18 Years - Acrotech Biopharma Inc.
Belinostat in Relapsed or Refractory Peripheral T-Cell LymphomaNCT00865969
Peripheral T-ce...
Belinostat
18 Years - Spectrum Pharmaceuticals, Inc
Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid TumorsNCT00413322
Tumor
belinostat
5-Fluorouracil ...
18 Years - Valerio Therapeutics
Belinostat in Treating Patients With Myelodysplastic SyndromesNCT00357162
de Novo Myelody...
Previously Trea...
Secondary Myelo...
belinostat
18 Years - National Cancer Institute (NCI)
Study of Volasertib and Belinostat in Patients With Relapsed and Refractory Aggressive B-cell and T-cell LymphomasNCT02875002
Relapsed and Re...
Lymphoma
volasertib
belinostat
18 Years - Yale University
Study of Oral PXD101 in Patients With Advanced Solid Tumors or LymphomaNCT00413075
Solid Tumor
Lymphoma
oral belinostat
18 Years - Valerio Therapeutics
Belinostat and Isotretinoin in Treating Patients With Solid Tumors That Are Metastatic or That Cannot Be Removed by SurgeryNCT00334789
Adult Solid Neo...
Belinostat
Isotretinoin
Pharmacological...
18 Years - National Cancer Institute (NCI)
PXD101 in Treating Patients With Relapsed or Refractory Aggressive B-Cell Non-Hodgkin's LymphomaNCT00303953
Recurrent Adult...
Recurrent Adult...
belinostat
18 Years - National Cancer Institute (NCI)
A Phase II Clinical Trial of PXD101 in Patients With Recurrent or Refractory Cutaneous and Peripheral T-Cell LymphomasNCT00274651
Cutaneous T-Cel...
Peripheral T-Ce...
Non-Hodgkin's L...
belinostat
18 Years - Valerio Therapeutics
A UGT1A1 Genotype-Directed Study of Belinostat Pharmacokinetics and ToxicityNCT06406465
Carcinoma, Neur...
Tumor, Neuroend...
Tumors, Neuroen...
Neuroendocrine;...
Small Cell; Rec...
Belinostat
Cisplatin
Etoposide
18 Years - 120 YearsNational Institutes of Health Clinical Center (CC)
Belinostat and Yttrium Y 90 Ibritumomab Tiuxetan in Patients W/Relapsed Aggressive B-Cell NHLNCT01686165
Anaplastic Larg...
Recurrent Adult...
Recurrent Mantl...
belinostat
rituximab
yttrium Y 90 ib...
18 Years - University of Arizona
Carfilzomib Plus Belinostat in Relapsed/Refractory NHLNCT02142530
Non-Hodgkin Lym...
Diffuse Large B...
Mantle Cell Lym...
Follicular Lymp...
Peripheral T-ce...
Carfilzomib
Belinostat
18 Years - Massachusetts General Hospital
Testing the Safety of the Anti-cancer Drugs Tazemetostat and Belinostat in Patients With Lymphomas That Have Resisted TreatmentNCT05627245
Recurrent B-Cel...
Recurrent Diffu...
Recurrent Non-H...
Recurrent Prima...
Recurrent T-Cel...
Recurrent Trans...
Refractory B-Ce...
Refractory Diff...
Refractory Non-...
Refractory Prim...
Refractory T-Ce...
Refractory Tran...
Belinostat
Biopsy
Biospecimen Col...
Computed Tomogr...
Pharmacokinetic...
Positron Emissi...
Tazemetostat
18 Years - National Cancer Institute (NCI)
MRSI to Predict Response to RT/TMZ ± Belinostat in GBMNCT02137759
Glioblastoma Mu...
Standard Radiat...
Standard Temozo...
Belinostat
18 Years - Emory University
Testing the Combination of Belinostat and SGI-110 (Guadecitabine) or ASTX727 for the Treatment of Unresectable and Metastatic Conventional ChondrosarcomaNCT04340843
Locally Advance...
Metastatic Prim...
Unresectable Pr...
Belinostat
Biopsy
Biospecimen Col...
Computed Tomogr...
Decitabine and ...
Guadecitabine
Magnetic Resona...
18 Years - National Cancer Institute (NCI)
Trial of PXD101 (Belinostat) in Combination With Idarubicin to Treat AML Not Suitable for Standard Intensive TherapyNCT00878722
Acute Myeloid L...
PXD101
idarubicin
18 Years - Valerio Therapeutics
Belinostat Combined With Azacitidine/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Refractory or Relapsed LymphomaNCT02701673
Lymphoma
Busulfan
Caphosol
Glutamine
Pyridoxine
Belinostat
Azacitidine
Gemcitabine
Melphalan
Stem Cell Trans...
15 Years - 65 YearsM.D. Anderson Cancer Center
A Study of Belinostat + Carboplatin or Paclitaxel or Both in Patients With Ovarian Cancer in Need of Relapse TreatmentNCT00421889
Ovarian Cancer
Epithelial Ovar...
Fallopian Tube ...
Bladder Cancer
belinostat
Paclitaxel
Carboplatin
18 Years - Valerio Therapeutics
A Phase I Study of Belinostat in Combination With Cisplatin and Etoposide in Adults With Small Cell Lung Carcinoma and Other Advanced CancersNCT00926640
Carcinoma Neuro...
Small Cell Lung...
Malignant Epith...
Belinostat
Cisplatin
Etoposide
18 Years - 99 YearsNational Institutes of Health Clinical Center (CC)
Belinostat and Isotretinoin in Treating Patients With Solid Tumors That Are Metastatic or That Cannot Be Removed by SurgeryNCT00334789
Adult Solid Neo...
Belinostat
Isotretinoin
Pharmacological...
18 Years - National Cancer Institute (NCI)
Phase I Mass Balance, PK and Safety Study of 14C-Labeled Belinostat in Patients With Advanced CancerNCT01583777
Advanced Cancer
Belinostat
18 Years - Acrotech Biopharma Inc.
Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid TumorsNCT00413322
Tumor
belinostat
5-Fluorouracil ...
18 Years - Valerio Therapeutics
Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid TumorsNCT00413322
Tumor
belinostat
5-Fluorouracil ...
18 Years - Valerio Therapeutics
Belinostat in Treating Patients With Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer or Ovarian Low Malignant Potential TumorsNCT00301756
Fallopian Tube ...
Primary Periton...
Recurrent Borde...
Recurrent Ovari...
Stage III Borde...
Stage III Ovari...
Stage IV Border...
Stage IV Ovaria...
Belinostat
Laboratory Biom...
18 Years - National Cancer Institute (NCI)
A Phase I Study of Belinostat in Combination With Cisplatin and Etoposide in Adults With Small Cell Lung Carcinoma and Other Advanced CancersNCT00926640
Carcinoma Neuro...
Small Cell Lung...
Malignant Epith...
Belinostat
Cisplatin
Etoposide
18 Years - 99 YearsNational Institutes of Health Clinical Center (CC)
Belinostat Combined With Azacitidine/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Refractory or Relapsed LymphomaNCT02701673
Lymphoma
Busulfan
Caphosol
Glutamine
Pyridoxine
Belinostat
Azacitidine
Gemcitabine
Melphalan
Stem Cell Trans...
15 Years - 65 YearsM.D. Anderson Cancer Center
Carfilzomib Plus Belinostat in Relapsed/Refractory NHLNCT02142530
Non-Hodgkin Lym...
Diffuse Large B...
Mantle Cell Lym...
Follicular Lymp...
Peripheral T-ce...
Carfilzomib
Belinostat
18 Years - Massachusetts General Hospital
Extension Study for Patients Who Had Not Met Criteria for Discontinuation in Previous Sponsored Belinostat TrialsNCT04184869
Solid Tumor
Hematological M...
Belinostat
Atazanavir
18 Years - Acrotech Biopharma Inc.
Tremelimumab + Durvalumab(MEDI4736)+ Belinostat in ARID1A Mutated Cancer Focus on Urothelial CarcinomaNCT05154994
Infiltrating Ur...
Locally Advance...
Metastatic Urot...
Unresectable Ur...
Belinostat
Durvalumab
18 Years - University of Utah
Belinostat Therapy With Zidovudine for Adult T-Cell Leukemia-LymphomaNCT02737046
Adult T-cell Le...
ATLL
Belinostat
Zidovudine
Interferon-Alfa...
Pegylated Inter...
18 Years - University of Miami
PXD101 as Second-Line Therapy in Treating Patients With Malignant Mesothelioma of the Chest That Cannot Be Removed By SurgeryNCT00365053
Advanced Malign...
Epithelial Meso...
Recurrent Malig...
Sarcomatous Mes...
belinostat
laboratory biom...
18 Years - National Cancer Institute (NCI)
Pevonedistat and Belinostat in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic SyndromeNCT03772925
Recurrent Acute...
Recurrent Myelo...
Refractory Acut...
Refractory Myel...
Belinostat
Pevonedistat
18 Years - National Cancer Institute (NCI)
A Phase II Study of Belinostat in Combination With Bortezomib in Patients With Relapsed, Refractory Multiple MyelomaNCT00431340
Multiple Myelom...
PXD101
18 Years - Valerio Therapeutics
Belinostat, Carboplatin and Paclitaxel (BelCaP) Compared to Carboplatin and Paclitaxel in Patients With Cancer of Unknown PrimaryNCT00873119
Carcinoma of Un...
belinostat, car...
carboplatin, pa...
18 Years - Valerio Therapeutics
A Study of Belinostat + Carboplatin or Paclitaxel or Both in Patients With Ovarian Cancer in Need of Relapse TreatmentNCT00421889
Ovarian Cancer
Epithelial Ovar...
Fallopian Tube ...
Bladder Cancer
belinostat
Paclitaxel
Carboplatin
18 Years - Valerio Therapeutics
Belinostat Therapy With Zidovudine for Adult T-Cell Leukemia-LymphomaNCT02737046
Adult T-cell Le...
ATLL
Belinostat
Zidovudine
Interferon-Alfa...
Pegylated Inter...
18 Years - University of Miami
PXD101 in Treating Patients With Acute Myeloid LeukemiaNCT00357032
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Recurrent Adult...
Untreated Adult...
belinostat
laboratory biom...
18 Years - National Cancer Institute (NCI)
Belinostat and Bortezomib in Treating Patients With Relapsed or Refractory Acute Leukemia or Myelodysplastic SyndromeNCT01075425
Acute Lymphocyt...
Acute Myeloid L...
Myelodysplastic...
Chronic Myeloge...
bortezomib
belinostat
laboratory biom...
western blottin...
pharmacological...
flow cytometry
18 Years - Virginia Commonwealth University
Trial of PXD101 (Belinostat) in Combination With Idarubicin to Treat AML Not Suitable for Standard Intensive TherapyNCT00878722
Acute Myeloid L...
PXD101
idarubicin
18 Years - Valerio Therapeutics
Testing the Combination of Belinostat and SGI-110 (Guadecitabine) or ASTX727 for the Treatment of Unresectable and Metastatic Conventional ChondrosarcomaNCT04340843
Locally Advance...
Metastatic Prim...
Unresectable Pr...
Belinostat
Biopsy
Biospecimen Col...
Computed Tomogr...
Decitabine and ...
Guadecitabine
Magnetic Resona...
18 Years - National Cancer Institute (NCI)
A Phase II Study of Belinostat in Combination With Bortezomib in Patients With Relapsed, Refractory Multiple MyelomaNCT00431340
Multiple Myelom...
PXD101
18 Years - Valerio Therapeutics
MRSI to Predict Response to RT/TMZ ± Belinostat in GBMNCT02137759
Glioblastoma Mu...
Standard Radiat...
Standard Temozo...
Belinostat
18 Years - Emory University
Trial of PXD101 (Belinostat) in Combination With Idarubicin to Treat AML Not Suitable for Standard Intensive TherapyNCT00878722
Acute Myeloid L...
PXD101
idarubicin
18 Years - Valerio Therapeutics
Pevonedistat and Belinostat in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic SyndromeNCT03772925
Recurrent Acute...
Recurrent Myelo...
Refractory Acut...
Refractory Myel...
Belinostat
Pevonedistat
18 Years - National Cancer Institute (NCI)
Belinostat in Treating Patients With Liver Cancer That Cannot Be Removed By SurgeryNCT00321594
Adult Primary H...
Advanced Adult ...
Localized Unres...
Recurrent Adult...
belinostat
18 Years - National Cancer Institute (NCI)
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: